Healthcare -
Biotechnology - NASDAQ - US
$ 15.49
-7.91 %
$ 475 M
Market Cap
-2.56
P/E
ANAB - TOTAL EQUITY
Total Equity ANAB - AnaptysBio, Inc.
88.1 M
LAST VALUE
-50.28%
2 YEAR CAGR
-28.94%
5 YEAR CAGR
89.83%
10 YEAR CAGR